URGN - UroGen Pharma GAAP EPS of -$0.97 misses by $0.08 revenue of $18.78M misses by $2.61M
2024-05-13 08:06:19 ET
More on UroGen Pharma
- UroGen: All Eyes On UGN-102
- UroGen Pharma Ltd. (URGN) Q4 2023 Earnings Call Transcript
- Urogen files patent suit against Teva over cancer therapy
- UroGen Pharma reports mixed Q4 results; initiates FY24 outlook
- Seeking Alpha’s Quant Rating on UroGen Pharma